Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Tyra Biosciences, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 59 | 62 | +3 |
| Shares | 36.5M | 35.8M | −705.9K (−1.9%) |
| Value | $502.1M | $495.2M | −$6.93M (−1.4%) |
New holders (9)
Institutions that held Tyra Biosciences, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kynam Capital Management, LP | 340,190 | $4.71M | 0.53% |
| EcoR1 Capital, LLC | 137,014 | $1.90M | 0.05% |
| Marshall Wace, LLP | 30,001 | $415.5K | 0.00% |
| American Century Companies Inc | 10,880 | $150.7K | 0.00% |
| Baker Bros. Advisors LP | 10,607 | $146.9K | 0.00% |
| Acuta Capital Partners, LLC | 8,867 | $122.8K | 0.07% |
| AJOVista, LLC | 4,235 | $58.7K | 0.07% |
| Qube Research & Technologies Ltd | 2,653 | $36.7K | 0.00% |
| GAMMA Investing LLC | 16 | $214 | 0.00% |
Sold out (6)
Institutions that held Tyra Biosciences, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Woodline Partners LP | 410,435 | $5.65M |
| Logos Global Management LP | 31,872 | $438.9K |
| Parkwood LLC | 16,967 | $234.0K |
| Susquehanna International Group, LLP | 11,872 | $163.5K |
| Corton Capital Inc. | 11,009 | $151.6K |
| Simplex Trading, LLC | 2,009 | $27.0K |